Cargando…

Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection

BACKGROUND: The authors aimed to create a novel model to predict lymphatic metastasis in thymic epithelial tumors. METHODS: Data of 1018 patients were collected from the Surveillance, Epidemiology, and End Results database from 2004 to 2015. To construct a nomogram, the least absolute shrinkage and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xinxin, Lu, Yaxin, Chen, Sai, Yang, Weilin, Xu, Bo, Zou, Jianyong, Chen, Zhenguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677650/
https://www.ncbi.nlm.nih.gov/pubmed/34448961
http://dx.doi.org/10.1245/s10434-021-10602-0
_version_ 1784616182781837312
author Cheng, Xinxin
Lu, Yaxin
Chen, Sai
Yang, Weilin
Xu, Bo
Zou, Jianyong
Chen, Zhenguang
author_facet Cheng, Xinxin
Lu, Yaxin
Chen, Sai
Yang, Weilin
Xu, Bo
Zou, Jianyong
Chen, Zhenguang
author_sort Cheng, Xinxin
collection PubMed
description BACKGROUND: The authors aimed to create a novel model to predict lymphatic metastasis in thymic epithelial tumors. METHODS: Data of 1018 patients were collected from the Surveillance, Epidemiology, and End Results database from 2004 to 2015. To construct a nomogram, the least absolute shrinkage and selection operator (LASSO) regression model was used to select candidate features of the training cohort from 2004 to 2013. A simple model called the Lymphatic Node Metastasis Risk Scoring System (LNMRS) was constructed to predict lymphatic metastasis. Using patients from 2014 to 2015 as the validation cohort, the predictive performance of the model was determined by receiver operating characteristic (ROC) curves. RESULTS: The LASSO regression model showed that age, extension, and histology type were significantly associated with lymph node metastasis, which were used to construct the nomogram. Through analysis of the area under the curve (AUC), the nomogram achieved a AUC value of 0.80 (95 % confidence interval [Cl] 0.75–0.85) in the training cohort and 0.82 (95 % Cl 0.70–0.93) in the validation cohort, and had closed calibration curves. Based on the nomogram, the authors constructed the LNMRS model, which had an AUC of 0.80 (95 % Cl 0.75–0.85) in the training cohort and 0.82 (95% Cl 0.70–0.93) in the validation cohort. The ROC curves indicated that the LNMRS had excellent predictive performance for lymph node metastasis. CONCLUSION: This study established a nomogram for predicting lymph node metastasis. The LNMRS model, constructed to predict lymphatic involvement of patients, was more convenient than the nomogram. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-10602-0.
format Online
Article
Text
id pubmed-8677650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-86776502022-01-04 Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection Cheng, Xinxin Lu, Yaxin Chen, Sai Yang, Weilin Xu, Bo Zou, Jianyong Chen, Zhenguang Ann Surg Oncol Thoracic Oncology BACKGROUND: The authors aimed to create a novel model to predict lymphatic metastasis in thymic epithelial tumors. METHODS: Data of 1018 patients were collected from the Surveillance, Epidemiology, and End Results database from 2004 to 2015. To construct a nomogram, the least absolute shrinkage and selection operator (LASSO) regression model was used to select candidate features of the training cohort from 2004 to 2013. A simple model called the Lymphatic Node Metastasis Risk Scoring System (LNMRS) was constructed to predict lymphatic metastasis. Using patients from 2014 to 2015 as the validation cohort, the predictive performance of the model was determined by receiver operating characteristic (ROC) curves. RESULTS: The LASSO regression model showed that age, extension, and histology type were significantly associated with lymph node metastasis, which were used to construct the nomogram. Through analysis of the area under the curve (AUC), the nomogram achieved a AUC value of 0.80 (95 % confidence interval [Cl] 0.75–0.85) in the training cohort and 0.82 (95 % Cl 0.70–0.93) in the validation cohort, and had closed calibration curves. Based on the nomogram, the authors constructed the LNMRS model, which had an AUC of 0.80 (95 % Cl 0.75–0.85) in the training cohort and 0.82 (95% Cl 0.70–0.93) in the validation cohort. The ROC curves indicated that the LNMRS had excellent predictive performance for lymph node metastasis. CONCLUSION: This study established a nomogram for predicting lymph node metastasis. The LNMRS model, constructed to predict lymphatic involvement of patients, was more convenient than the nomogram. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-10602-0. Springer International Publishing 2021-08-27 2022 /pmc/articles/PMC8677650/ /pubmed/34448961 http://dx.doi.org/10.1245/s10434-021-10602-0 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Thoracic Oncology
Cheng, Xinxin
Lu, Yaxin
Chen, Sai
Yang, Weilin
Xu, Bo
Zou, Jianyong
Chen, Zhenguang
Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
title Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
title_full Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
title_fullStr Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
title_full_unstemmed Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
title_short Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
title_sort lymphatic node metastasis risk scoring system: a novel instrument for predicting lymph node metastasis after thymic epithelial tumor resection
topic Thoracic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677650/
https://www.ncbi.nlm.nih.gov/pubmed/34448961
http://dx.doi.org/10.1245/s10434-021-10602-0
work_keys_str_mv AT chengxinxin lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection
AT luyaxin lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection
AT chensai lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection
AT yangweilin lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection
AT xubo lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection
AT zoujianyong lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection
AT chenzhenguang lymphaticnodemetastasisriskscoringsystemanovelinstrumentforpredictinglymphnodemetastasisafterthymicepithelialtumorresection